Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

VASCULAB SPECTRUM ANALYZER #SP25

K-Number: K820898 · 1982-04-21

ApplicantMedasonics, Inc.
Decision Date1982-04-21
Product CodeDXG
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

VASCULAB SPECTRUM ANALYZER #SP25 is the device name listed in this FDA 510(k) record. The listed applicant is Medasonics, Inc.. It received FDA 510(k) clearance on 1982-04-21 under 510(k) number K820898. The device is classified under product code DXG. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the VASCULAB SPECTRUM ANALYZER #SP25?

VASCULAB SPECTRUM ANALYZER #SP25 is a medical device that received FDA 510(k) clearance on 1982-04-21. The listed applicant is Medasonics, Inc.. The 510(k) number is K820898.

When did VASCULAB SPECTRUM ANALYZER #SP25 receive FDA 510(k) clearance?

VASCULAB SPECTRUM ANALYZER #SP25 received FDA 510(k) clearance on 1982-04-21, under 510(k) number K820898.

Who is the listed applicant for VASCULAB SPECTRUM ANALYZER #SP25?

The FDA 510(k) record lists Medasonics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for VASCULAB SPECTRUM ANALYZER #SP25?

The FDA product code for VASCULAB SPECTRUM ANALYZER #SP25 is DXG.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Medasonics, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K991441CADENCE DOPPLER ULTRASOUND SYSTEMK962796NEUROGUARD TRANSCRANIAL DOPPLER ULTRASOUND SYSTEMK961116FIRST BEAT/CARDIO BEAT/CALCK914862CEREBROVASCULAR DIAGNOSTIC SYSTEM; CDSK911453OBTRASOUND STETHOSCOPE FETAL CALCK882018MEDACORD PVL, PERSONAL VASCULAR LABORATORY

View all 19 devices →

Related Devices (Code: DXG)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K253092Argos Infinity (Rev. 1.0)Retia Medical Systems, Inc.K251275VitalStream ART Connect; VitalStream-HemoCaretaker MedicalK232048Cogent™ Hemodynamic Monitoring System; Cogent™ HMSIcu MedicalK212529Hypotension Decision Assist Model HDA-OR2Directed Systems, Ltd.K192169PulsioFlex Monitoring System with ProAQT SensorPulsion Medical Systems SEK193179EV1000 Clinical PlatformEdwards Lifesciences, LLC

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑